Free Trial

Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Amdocs Limited (NASDAQ:DOX)

Amdocs logo with Computer and Technology background

Key Points

  • Rep. Gilbert Ray Cisneros, Jr. sold shares of Amdocs Limited (NASDAQ:DOX) valued between $1,001 and $15,000 on August 26th, 2025.
  • Amdocs recently reported quarterly earnings with an EPS of $1.72, exceeding the consensus estimate by $0.01, despite an 8.4% decline in revenue compared to the previous year.
  • The company declared a quarterly dividend of $0.527 per share, representing an annualized dividend yield of 2.5%, payable on October 31st.
  • MarketBeat previews the top five stocks to own by October 1st.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Amdocs Limited (NASDAQ:DOX). In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Amdocs stock on August 26th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 9/2/2025.
  • Sold $1,001 - $15,000 in shares of Chart Industries NYSE: GTLS on 9/2/2025.
  • Purchased $1,001 - $15,000 in shares of Avient NYSE: AVNT on 9/2/2025.
  • Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 8/27/2025.
  • Purchased $1,001 - $15,000 in shares of Intapp NASDAQ: INTA on 8/26/2025.
  • Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 8/26/2025.
  • Purchased $1,001 - $15,000 in shares of Waters NYSE: WAT on 8/26/2025.
  • Purchased $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 8/26/2025.
  • Sold $1,001 - $15,000 in shares of Fortive NYSE: FTV on 8/26/2025.
  • Sold $1,001 - $15,000 in shares of GoDaddy NYSE: GDDY on 8/26/2025.

Amdocs Price Performance

Shares of DOX stock traded down $0.17 during mid-day trading on Tuesday, reaching $84.02. The stock had a trading volume of 334,743 shares, compared to its average volume of 728,061. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23. The business has a 50-day simple moving average of $87.03 and a 200 day simple moving average of $88.52. Amdocs Limited has a 12-month low of $78.61 and a 12-month high of $95.41. The company has a market cap of $9.48 billion, a P/E ratio of 17.05, a price-to-earnings-growth ratio of 1.55 and a beta of 0.54.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The company had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.13 billion. During the same period last year, the company earned $1.62 EPS. The firm's revenue for the quarter was down 8.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a $0.527 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.5%. Amdocs's dividend payout ratio is currently 42.80%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOX. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Wolfe Research assumed coverage on Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating for the company. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $105.33.

Read Our Latest Stock Analysis on DOX

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Pzena Investment Management LLC raised its holdings in shares of Amdocs by 2.1% during the second quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company's stock valued at $597,719,000 after buying an additional 132,463 shares during the last quarter. LSV Asset Management grew its position in Amdocs by 6.6% in the second quarter. LSV Asset Management now owns 3,391,510 shares of the technology company's stock worth $309,441,000 after buying an additional 211,009 shares during the last quarter. Alyeska Investment Group L.P. boosted its stake in shares of Amdocs by 38.6% during the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock worth $213,174,000 after acquiring an additional 648,693 shares in the last quarter. Brandes Investment Partners LP grew its holdings in shares of Amdocs by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,328,804 shares of the technology company's stock worth $212,481,000 after acquiring an additional 27,581 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of Amdocs by 23.5% during the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock valued at $205,219,000 after purchasing an additional 426,911 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Amdocs

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.